| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |